• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Quantifying relative within-host replication fitness in influenza virus competition experiments

tetano

Editor, Senior Moderator
J Theor Biol. 2015 Jul 15. pii: S0022-5193(15)00332-X. doi: 10.1016/j.jtbi.2015.07.003. [Epub ahead of print]
[h=1]Quantifying relative within-host replication fitness in influenza virus competition experiments.[/h] Petrie SM[SUP]1[/SUP], Butler J[SUP]2[/SUP], Barr IG[SUP]3[/SUP], McVernon J[SUP]4[/SUP], Hurt AC[SUP]3[/SUP], McCaw JM[SUP]5[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Through accumulation of genetic mutations in the neuraminidase gene, the influenza virus can become resistant to antiviral drugs such as oseltamivir. Quantifying the fitness of emergent drug-resistant influenza viruses, relative to contemporary circulating viruses, provides valuable information to complement existing efforts in the surveillance of drug-resistance. We have previously developed a co-infection based method for the assessment of the relative in vivo fitness of two competing viruses. We have also introduced a model of within-host co-infection dynamics that enables relative within-host fitness to be quantified in these competitive-mixtures experiments. The model assumed that fitness differences between co-infecting strains were mediated by strain-dependent viral production rates from infected epithelial cells. Here we extend the model to enable a more complete exploration of biological processes that may differ between virus pairs and hence generate fitness differences. We use the extended model to re-analyse data from competitive-mixtures experiments that investigated the fitness of oseltamivir-resistant (OR) H1N1 pandemic 2009 ("H1N1pdm09") viruses that emerged during a community outbreak in Australia in 2011. Results are consistent with those of our previous analysis, suggesting that the within-host replication fitness of these OR viruses is not compromised relative to that of related oseltamivir-susceptible (OS) strains, and that potentially permissive mutations in the neuraminidase gene (V241I and N369K) significantly enhance the fitness of H1N1pdm09 OR viruses. These results are consistent regardless of the hypothesised biological cause of fitness difference.
Copyright ? 2015. Published by Elsevier Ltd.


[h=4]KEYWORDS:[/h] Drug-resistance; Influenza; Mathematical model; Pathogen fitness; Viral kinetics

PMID: 26188087 [PubMed - as supplied by publisher]
 
Back
Top Bottom